Our results suggest that the positive association between CSF GFAP and glucose uptake could uncouple in regions with higher damage but could also be partially maintained in the frontal lobes in symptomatic AD, even in the presence of tau pathology. This evidence concerns the gene MAPT and Alzheimer disease.